The high-tech pharmaceutical products imports to Austria showed considerable growth from 2013 to 2023, starting at €3.83 billion in 2013 and reaching €7.67 billion in 2023. Over this period, the imports experienced fluctuations with significant peaks and occasional declines. Notable year-on-year variations include sharp increases in 2015 (16.8%) and 2021 (30.83%), and notable declines in 2018 (-3.92%) and 2020 (-6.15%). The five-year compound annual growth rate (CAGR) stood at 6.53% by 2023.
The forecast for the future from 2024 to 2028 shows a continued upward trend, with imports expected to grow from €8.02 billion in 2024 to €9.37 billion by 2028. The forecasted five-year CAGR is 3.17% with an anticipated growth rate of 16.87% over this period.
Future trends to watch include advancements in pharmaceutical technology, regulatory changes in the European Union, and global economic conditions that could impact Austria's import capacity. Additionally, shifts in healthcare demands and innovation in high-tech pharmaceutical products may further influence these trends.
